BCYC
Price
$3.81
Change
-$0.08 (-2.06%)
Updated
Sep 15, 10:56 AM (EDT)
Capitalization
272.62M
44 days until earnings call
Intraday BUY SELL Signals
DNLI
Price
$20.44
Change
-$0.78 (-3.68%)
Updated
Sep 15, 10:58 AM (EDT)
Capitalization
3.39B
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs DNLI

BCYC vs DNLI Comparison Chart in %
View a ticker or compare two or three
VS
BCYC vs. DNLI commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and DNLI is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.39B) has a higher market cap than BCYC($273M). DNLI YTD gains are higher at: 28.528 vs. BCYC (-45.056). BCYC has higher annual earnings (EBITDA): -183.2M vs. DNLI (-526.81M). DNLI has more cash in the bank: 710M vs. BCYC (510M). BCYC has less debt than DNLI: BCYC (14.7M) vs DNLI (32.2M). BCYC has higher revenues than DNLI: BCYC (61.2M) vs DNLI (3.6M).
BCYCDNLIBCYC / DNLI
Capitalization273M3.39B8%
EBITDA-183.2M-526.81M35%
Gain YTD-45.05628.528-158%
P/E RatioN/AN/A-
Revenue61.2M3.6M1,698%
Total Cash510M710M72%
Total Debt14.7M32.2M46%
FUNDAMENTALS RATINGS
BCYC vs DNLI: Fundamental Ratings
BCYC
DNLI
OUTLOOK RATING
1..100
6050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
7458
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
1150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (9) in the null industry is significantly better than the same rating for DNLI (90) in the Biotechnology industry. This means that BCYC’s stock grew significantly faster than DNLI’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as DNLI (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to DNLI’s over the last 12 months.

BCYC's SMR Rating (97) in the null industry is in the same range as DNLI (98) in the Biotechnology industry. This means that BCYC’s stock grew similarly to DNLI’s over the last 12 months.

DNLI's Price Growth Rating (58) in the Biotechnology industry is in the same range as BCYC (74) in the null industry. This means that DNLI’s stock grew similarly to BCYC’s over the last 12 months.

DNLI's P/E Growth Rating (98) in the Biotechnology industry is in the same range as BCYC (100) in the null industry. This means that DNLI’s stock grew similarly to BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCYCDNLI
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (BCYC: $3.89 vs. DNLI: $21.22)
Brand notoriety: BCYC and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 58% vs. DNLI: 69%
Market capitalization -- BCYC: $272.62M vs. DNLI: $3.39B
BCYC [@Biotechnology] is valued at $272.62M. DNLI’s [@Biotechnology] market capitalization is $3.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green while DNLI’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 3 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • DNLI’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than DNLI.

Price Growth

BCYC (@Biotechnology) experienced а -9.53% price change this week, while DNLI (@Biotechnology) price change was -4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.98%. For the same industry, the average monthly price growth was -6.07%, and the average quarterly price growth was +3.24%.

Reported Earning Dates

BCYC is expected to report earnings on Oct 29, 2026.

DNLI is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BCYC
Daily Signal:
Gain/Loss:
DNLI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CONL6.290.97
+18.23%
GraniteShares 2x Long COIN Daily ETF
ERY8.810.18
+2.09%
Direxion Daily Energy Bear 2X ETF
XMAR43.42-0.04
-0.09%
FT Vest U.S. Eq Enh & ModBufETF-Mar
TFJL18.64-0.04
-0.20%
Innovator 20 Year Treasury Bond 5 Floor ETF
USRT64.21-0.27
-0.42%
iShares Core US REIT ETF

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.78%
DNLI - BCYC
48%
Loosely correlated
+0.62%
PCVX - BCYC
48%
Loosely correlated
+0.12%
MGTX - BCYC
47%
Loosely correlated
+0.70%
BHVN - BCYC
46%
Loosely correlated
-0.55%
NGNE - BCYC
46%
Loosely correlated
-0.76%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with VIR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+0.62%
VIR - DNLI
52%
Loosely correlated
+1.37%
VCYT - DNLI
50%
Loosely correlated
+0.83%
EDIT - DNLI
49%
Loosely correlated
+1.48%
BCYC - DNLI
49%
Loosely correlated
+0.78%
PCVX - DNLI
48%
Loosely correlated
+0.12%
More